Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1/2 1

Status

Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Gynecologic 3Classical hematology 3Plasma cell 2Lymphoid 2Thoracic 1Breast 1

Conditions

Ovarian Neoplasms 1Iron Deficiencies 1Gynecologic Cancer 1Carcinoma, Ovarian Epithelial 1Anemia, Iron-Deficiency 1Anemia 1Anaemia in Ovarian Carcinoma 1

Interventions

Paclitaxel 575Carboplatin 521Cisplatin 351Bevacizumab 252pembrolizumab 228Gemcitabine 157Topotecan 128Cyclophosphamide 128liposomal doxorubicin 127olaparib 120Taxes 113Radiotherapy 110Docetaxel 94Brachytherapy 89Doxorubicin 84Drug Therapy 81niraparib 75Nivolumab 71Magnetic Resonance Spectroscopy 71Specimen Handling 65fludarabine 57Biopsy 55Hyperthermic Intraperitoneal Chemotherapy 53Filgrastim 52Letrozole 50Oxaliplatin 48durvalumab 47Immunoglobulin G 47atezolizumab 46Platinum 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Ferric Oxide, Saccharated × Gynecologic × Clear all
NCT06248749 2024-02-08

Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer

University of Saskatchewan

Phase 3 Not yet recruiting
200 enrolled
Gynecologic

Anaemia in Ovarian Carcinoma

NCT03933813 2023-01-05

Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients

University of Wisconsin, Madison

Phase 1/2 Terminated
9 enrolled
Classical hematologyGynecologic

Carcinoma, Ovarian Epithelial, Iron Deficiencies, Anemia, Ovarian Neoplasms, Anemia, Iron-Deficiency

NCT01435200 2017-02-01

Intravenous Iron in Gynecologic Cancer Patients Receiving Chemotherapy

Chulalongkorn University

Phase 3 Completed
64 enrolled
Gynecologic

Gynecologic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡